Document is current

Article History

Accepted: 21 September 2021

First Online: 29 October 2021

Declarations

:

: The ASOS programme was funded by the <i>Agence Française de Sécurité Sanitaire des Produits de Santé</i> (French Drug Agency).

: Joelle Perri-Plandé, Ghada Miremont-Salamé, Joëlle Micallef, Cameron Herman, Marie Baumevieille, Frédéric Abriat, Maryse Lapeyre-Mestre, Françoise Haramburu, Amélie Daveluy and the French Addictovigilance Network have no potential conflict of interest related to the content of this article.

: This study did not require an opinion from an ethics committee, according to French legislation at the time the study began in 2001. The clinical research department of the Bordeaux University Hospital contacted the French Health Authority (<i>Direction Générale de la Santé</i>) in 2017 to confirm that this study did not fall within the scope of Research Involving Human Persons. It is an observational study with completely anonymous data collection, no patient identifiers and no possibility of data feedback.

: Not applicable.

: Not applicable.

: The data that support the findings of this work are available from the corresponding author on reasonable request.

: Not applicable.

: All of the authors contributed: GMS, FH, AD and FA developed the study protocol; JPP and CH performed data management and analysis; JPP wrote the first draft of the paper; AD wrote the article; FH, GMS, JM, MB and MLM reviewed the article before submission. The French Addictovigilance Network collaborators collected the field data. All authors read and approved the final version.